Lazard Asset Management’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.76M Buy
+92,249
New +$1.6M ﹤0.01% 1045
2023
Q1
Sell
-2,127
Closed -$84K 2430
2022
Q4
$84K Hold
2,127
﹤0.01% 1592
2022
Q3
$98K Hold
2,127
﹤0.01% 1485
2022
Q2
$91K Buy
2,127
+918
+76% +$42K ﹤0.01% 1543
2022
Q1
$65K Buy
+1,209
New +$61.8K ﹤0.01% 1613
2020
Q2
Sell
-1,426
Closed -$56K 1702
2020
Q1
$56K Buy
1,426
+793
+125% +$35.5K ﹤0.01% 1140
2019
Q4
$29K Buy
633
+282
+80% +$10.9K ﹤0.01% 1160
2019
Q3
$12K Buy
+351
New +$12.2K ﹤0.01% 1263

Other funds holding KIDS

Lazard Asset Management's KIDS Position: Q2 2026 in Review

Lazard Asset Management opened a new position in OrthoPediatrics (KIDS) in Q2 2026: 92,249 shares worth $1.76M. The stake represents ﹤0.01% of the portfolio and ranks #1045 among its holdings. This is a return to the name: Lazard Asset Management previously reported a position in KIDS as recently as Q4 2022.

Lazard Asset Management first reported a position in KIDS in Q3 2019 and has held it in 8 quarters since. 119 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Lazard Asset Management held 92,249 shares of OrthoPediatrics worth $1.76M as of Q2 2026.
  • OrthoPediatrics was a new Lazard Asset Management position in Q2 2026.
  • OrthoPediatrics made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1045 holding.
  • Lazard Asset Management first reported a position in OrthoPediatrics in Q3 2019 and has held it in 8 quarters since.
  • 119 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.